Gratus Capital’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
$1.04M Buy
11,303
+1,407
+14% +$130K 0.04% 174
2024
Q1
$946K Sell
9,896
-3,460
-26% -$331K 0.04% 168
2023
Q4
$1.02M Sell
13,356
-831
-6% -$63.4K 0.06% 138
2023
Q3
$983K Buy
14,187
+194
+1% +$13.4K 0.07% 131
2023
Q2
$1.32M Sell
13,993
-425
-3% -$40.1K 0.09% 115
2023
Q1
$1.19M Sell
14,418
-1,862
-11% -$154K 0.09% 111
2022
Q4
$1.21M Sell
16,280
-112,122
-87% -$8.37M 0.1% 114
2022
Q3
$10.6M Buy
128,402
+110,827
+631% +$9.16M 1.12% 36
2022
Q2
$1.67M Hold
17,575
0.19% 87
2022
Q1
$2.07M Sell
17,575
-1,216
-6% -$143K 0.2% 83
2021
Q4
$2.43M Sell
18,791
-6
-0% -$777 0.23% 77
2021
Q3
$2.13M Hold
18,797
0.23% 78
2021
Q2
$1.95M Sell
18,797
-24,000
-56% -$2.49M 0.22% 81
2021
Q1
$3.58M Sell
42,797
-4,800
-10% -$402K 0.43% 75
2020
Q4
$4.34M Sell
47,597
-2,893
-6% -$264K 0.58% 60
2020
Q3
$4.03M Hold
50,490
0.63% 59
2020
Q2
$3.49M Sell
50,490
-3,126
-6% -$216K 0.59% 59
2020
Q1
$3.37M Hold
53,616
0.63% 51
2019
Q4
$4.17M Sell
53,616
-3,300
-6% -$257K 0.63% 54
2019
Q3
$4.17M Hold
56,916
0.68% 51
2019
Q2
$3.51M Sell
56,916
-1,125
-2% -$69.3K 0.57% 59
2019
Q1
$3.7M Sell
58,041
-4,383
-7% -$280K 0.62% 56
2018
Q4
$3.19M Sell
62,424
-2,202
-3% -$112K 0.65% 56
2018
Q3
$3.75M Sell
64,626
-996
-2% -$57.8K 0.51% 52
2018
Q2
$3.18M Hold
65,622
0.47% 57
2018
Q1
$3.05M Hold
65,622
0.44% 61
2017
Q4
$2.47M Hold
65,622
0.32% 75
2017
Q3
$2.39M Hold
65,622
0.33% 74
2017
Q2
$2.59M Buy
+65,622
New +$2.59M 0.37% 69
2017
Q1
Sell
-66,042
Closed -$2.06M 179
2016
Q4
$2.06M Buy
+66,042
New +$2.06M 0.31% 75